Chennai: Joining the international quest for a vaccine against Covid-19, two Chennai-based institutions will offer the Oxford vaccine, one of the most promising candidates against the novel coronavirus SARS-CoV-2, to nearly 300 volunteers. This is a part of the multi-centric clinical trial in India
Final clinical trials for a coronavirus vaccine, developed by AstraZeneca and Oxford University, have been put on hold after a participant had an adverse reaction in the UK.
AstraZeneca described it as a "routine" pause in the case of "an unexplained illness".